Skip to main content
VCbacked
Log inGet Started

Vaxess Technologies

Cambridge, United States

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

$9.0M raised
Apr 2025
Venture - Series Unknown
BiotechnologyHealth CareMedical

Top Investors

National Science FoundationBill & Melinda Gates FoundationRA Capital ManagementVerizonUlu Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vaxess Technologies

How much funding has Vaxess Technologies raised?
Vaxess Technologies has raised $9.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Who are Vaxess Technologies's investors?
Vaxess Technologies's investors include National Science Foundation, Bill & Melinda Gates Foundation, RA Capital Management, Verizon, Ulu Ventures.
Where is Vaxess Technologies headquartered?
Vaxess Technologies is headquartered in Cambridge, United States.
What does Vaxess Technologies do?
Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
What stage is Vaxess Technologies at?
Vaxess Technologies is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Vaxess Technologies — Funding & Investors." VCBacked, April 9, 2025, https://www.vcbacked.co/company/vaxess-technologies. Accessed June 4, 2026.
APA
VCBacked. (2025). Vaxess Technologies — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/vaxess-technologies
Wikipedia (cite web)
{{cite web |title=Vaxess Technologies — Funding & Investors |url=https://www.vcbacked.co/company/vaxess-technologies |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong